Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
603939.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
-14%
0.36
vs 0.42
Q3.23
-15%
0.29
vs 0.34
Q4.23
-34%
0.41
vs 0.62
Q1.24
+20%
0.4
vs 0.33
Q2.24
-11%
0.32
vs 0.36
Q3.24
-10%
0.26
vs 0.29
Q4.24
-20%
0.33
vs 0.41
Q1.25
-10%
0.36
vs 0.4
Q2.25
+12%
0.36
vs 0.32
Q3.25
+27%
0.33
vs 0.26
Sales Growth
YoY
Current
Estimates
Q2.23
+18%
5.4B vs 4.6B
Q3.23
+13%
5.2B vs 4.6B
Q4.23
+2%
6.7B vs 6.5B
Q1.24
+13%
5.9B vs 5.3B
Q2.24
+6%
5.8B vs 5.4B
Q3.24
+5%
5.5B vs 5.2B
Q4.24
+3%
6.8B vs 6.7B
Q1.25
+1%
6B vs 5.9B
Q2.25
+11%
6.4B vs 5.8B
Q3.25
+12%
6.1B vs 5.5B
Return on Equity
QoQ
Q2.23
+4%
0.04
vs 0.04
Q3.23
+3%
0.03
vs 0.04
Q4.23
+4%
0.04
vs 0.03
Q1.24
+4%
0.04
vs 0.04
Q2.24
+4%
0.04
vs 0.04
Q3.24
+3%
0.03
vs 0.04
Q4.24
+4%
0.04
vs 0.03
Q1.25
+4%
0.04
vs 0.04
Institutionnal Ownership
Yifeng Pharmacy Chain Co., Ltd. retails pharmaceutical products in China. As of March 31, 2021, it operates approximately 6,279 pharmaceutical chain stores in Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The company was founded in 2001 and is based in Changsha, China.
SHH
-0.35Â ( -1.41%)
Relative Strenght
Volume Buzz
-36%
Earning Acce
Yes
Dist 52w H.
16%Forecast
397%2026-Revenue
361%2026-EPS
641%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 603939.SS compares to sector?